Matthias Marx - Patents
www.freshpatents.com
Inventors: Matthias Marx, Susanne Grafe, Reiner Benecke, Dirk Dressler High frequency application of botulinum toxin therapy
Overall Clinical Efficacy and Overall Tolerability of NT Wiley Online Library
onlinelibrary.wiley.com
— Poster 57: Overall Clinical Efficacy and Overall Tolerability of NT 201 (Botulinum Neurotoxin Free From Complexing Proteins). Susanne Grafe,.
Efficacy and safety of treatment with Incobotulinum toxin A ...Acta Orthopaedica
www.medicaljournals.se
... Susanne Grafe , Irena Pulte DOI: Abstract. Objective: To investigate the efficacy and safety of repeated treatment with incobotulinum ...
A randomized, double-blind study of repeated incobotulinumtoxinA...
www.deepdyve.com
Susanne Grafe. •. Angelika Hanschmann. •. Cynthia L. Comella. Received: 9 January Accepted: 23 May Published online:
efficacy and safety of treatment with incobotulinum toxin aMedical Journals Sweden
medicaljournalssweden.se
von P Kaňovský · · Zitiert von: 108 — Thomas Platz, MD, PhD4, Georg Comes5, Susanne Grafe, MD5 and Irena Pulte, MD5. From the 1Department of Neurology, Palacky University Medical School, ...
PM&R | Vol 2, Issue 9, Suppl, Pages A1-A10, S1-S206 (September 2010)...
www.sciencedirect.com
Poster 57: Overall Clinical Efficacy and Overall Tolerability of NT 201 (Botulinum Neurotoxin Free From Complexing Proteins). Susanne Grafe, Georg Comes, ...
Susanne Grafe – ScienceOpen
www.scienceopen.com
Botulinum Neurotoxin Type A Free of Complexing Proteins (XEOMIN??) in Focal Dystonia. Authors: Wolfgang H Jost, J??rg Bl??mel, Susanne Grafe.
IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical...
core.ac.uk
Susanne Grafe e, Angelika Hanschmann e a Movement Disorders Center of Arizona, E. Ironwood Square Drive, Suite 225, Scottsdale, ...
Alle Infos zum Namen "Susanne Grafe"
DE D1 - DEVICE AND METHOD FOR THE ...Google Patents
patents.google.com
ES T Susanne Grafe Botulinum toxin to introduce temporary infertility in a vertebrate (for example, a human being). LT T ...
"A randomized, double-blind study of repeated ...University of Memphis Digital Commons
digitalcommons.memphis.edu
von VGH Evidente · · Zitiert von: 75 — Susanne Grafe, Merz GmbH & Co. KGaA · Angelika Hanschmann, Merz GmbH & Co. KGaA · Cynthia L. Comella, Rush University. Abstract. IncobotulinumtoxinA (Xeomin®, ...
Botulinum neurotoxin type A free of complexing proteins ...National Institutes of Health (.gov)
pubmed.ncbi.nlm.nih.gov
von WH Jost · · Zitiert von: 161 — Susanne Grafe. Affiliation. 1 Department of Neurology and Clinical Neurophysiology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany. jost.neuro@dkd ...
Content - Volume 43, Issue 6Medical Journals Sweden
www.medicaljournals.se
... Susanne Grafe , Irena Pulte. Objective: To investigate the efficacy and safety of repeated treatment with incobotulinum toxin A (botulinum neurotoxin type A ...
IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or ...cyberleninka.org › article
cyberleninka.org
Comella, Susanne Grafe, et al. Abstract Typically, botulinum toxin injections ... Susanne Grafe: Conception or design of the study, data acquisition, data ...
Efficacy and safety of incobotulinumtoxinA (NT 201, ...Europe PMC
europepmc.org
von J Jankovic · · Zitiert von: 100 — ... Susanne Grafe. Search articles by 'Susanne Grafe' · Grafe S. Author information. Affiliations. 1 author. 1. Department of Neurology, Baylor College of Medicine ...
Efficacy and safety of incobotulinumtoxinA (NT 201, ...Journal of the Neurological Sciences
www.jns-journal.com
Truong, Angelika Hanschmann, Susanne Grafe. Journal of the Neurological Sciences. Volume 308 Issue 1 Pages (September 2011). DOI: j.jns
Efficacy and safety of incobotulinumtoxinA (NT 201, ...Read by QxMD
read.qxmd.com
... Susanne Grafe. Journal of the Neurological Sciences September 16. OBJECTIVE: IncobotulinumtoxinA differs from available formulations in that it does not ...
Neurophysiological double-blind trial of a botulinum ...National Institutes of Health (.gov)
pubmed.ncbi.nlm.nih.gov
von K Wohlfarth · · Zitiert von: 84 — Authors. Kai Wohlfarth , Christian Müller, Irena Sassin, Georg Comes, Susanne Grafe. Affiliation. 1 Humaine Klinikum Bad Saarow, Germany. PMID: ; DOI ...
Neurophysiological double-blind trial of a botulinum ...Read by QxMD
read.qxmd.com
Kai Wohlfarth, Christian Müller, Irena Sassin, Georg Comes, Susanne Grafe. Clinical Neuropharmacology OBJECTIVE: Safety and efficacy of botulinum ...
Efficacy and safety of treatment with incobotulinum toxin A ...medicaljournalssweden.se › jrm › article › view
medicaljournalssweden.se
· Comella, Susanne Grafe, Angelika Hanschmann (2014). IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical dystonia according ...
Botulinum toxin to introduce temporary infertility in a ...Google
patents.google.com
Application filed by Susanne Grafe, Florian Prof. Dr. med. Heinen Application granted Publication of ES T3.
Botulinum neurotoxin type A free of complexing proteins ...Gale
link.gale.com
Authors: Wolfgang H. Jost, Jorg Blumel and Susanne Grafe. Date: Mar. 15, From: Drugs(Vol. 67, Issue 5). Publisher: Wolters Kluwer Health, Inc.
Botulinum neurotoxin type A free of complexing proteins (XEOMIN[R])...
go.gale.com
includes Botulinum neurotoxin type A free of complexing proteins by Wolfgang H. Jost, Jorg Blumel, and Susanne Grafe. Click to explore.
Efficacy and safety of treatment with incobotulinum toxin A...
read.qxmd.com
Petr Kaňovský, Jaroslaw Slawek, Zoltan Denes, Thomas Platz, Georg Comes, Susanne Grafe, Irena Pulte. Journal of Rehabilitation Medicine 2011, 43 (6):
Most recent papers with the keyword NT-201 | Read by QxMDread.qxmd.com › keyword
read.qxmd.com
Joseph Jankovic, Cynthia Comella, Angelika Hanschmann, Susanne Grafe. IncobotulinumtoxinA (NT 201, Xeomin) is a highly purified botulinum neurotoxin type ...
Verwandte Suchanfragen zu Susanne Grafe
| Irena Pulte Angelika Hanschmann Jorg Blumel |
Person "Grafe" (3) Vorname "Susanne" (57036) Name "Grafe" (670) |
sortiert nach Relevanz / Datum